SUBLIVAC® Birch PROBE Study
NCT00932607
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class
Conditions
Seasonal Rhinitis and/or Rhinoconjunctivitis
Birch Pollen Allergy
Interventions
DRUG:
sublingual immunotherapy
Sponsor
HAL Allergy